Omega Fund Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,226
Closed -$1.15M 25
2021
Q3
$1.15M Hold
5,226
0.13% 26
2021
Q2
$3.48M Hold
5,226
0.39% 19
2021
Q1
$4.54M Hold
5,226
0.43% 19
2020
Q4
$4.85M Hold
5,226
0.73% 14
2020
Q3
$5.37M Hold
5,226
1.45% 12
2020
Q2
$5.29M Hold
5,226
1.45% 12
2020
Q1
$4.54M Hold
5,226
1.88% 11
2019
Q4
$5.6M Hold
5,226
1.78% 10
2019
Q3
$4.83M Hold
5,226
1.49% 11
2019
Q2
$5.9M Hold
5,226
1.51% 10
2019
Q1
$7.1M Hold
5,226
2.28% 7
2018
Q4
$6.05M Hold
5,226
4.48% 6
2018
Q3
$7.94M Hold
5,226
3.75% 7
2018
Q2
$8.18M Hold
5,226
6.03% 6
2018
Q1
$6.04M Hold
5,226
5.93% 6
2017
Q4
$6.19M Sell
5,226
-7,348
-58% -$9.21M 4.48% 7
2017
Q3
$16.9M Sell
12,574
-12,526
-50% -$13.2M 9.57% 3
2017
Q2
$20.3M Sell
25,100
-7,400
-23% -$5.15M 12.65% 3
2017
Q1
$20M Sell
32,500
-387
-1% -$236K 13.02% 3
2016
Q4
$17.6M Hold
32,887
14.28% 4
2016
Q3
$17M Hold
32,887
12.99% 4
2016
Q2
$13.5M Hold
32,887
10.01% 4
2016
Q1
$17.5M Hold
32,887
12.14% 4
2015
Q4
$25.1M Sell
32,887
-2,000
-6% -$1.33M 13.94% 4
2015
Q3
$19.1M Sell
34,887
-4,000
-10% -$2.42M 10.76% 4
2015
Q2
$22.8M Hold
38,887
11.54% 4
2015
Q1
$30.5M Hold
38,887
13.19% 4
2014
Q4
$26.6M Buy
+38,887
New +$25M 12.23% 3

Other funds holding KYNB

Omega Fund Management's KYNB Position: Q4 2021 in Review

Omega Fund Management sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 5,226 shares — an estimated $1.15M sold.

Omega Fund Management first reported a position in KYNB in Q4 2014 and held it in 28 quarters. The position peaked at $30.5M in Q1 2015. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Omega Fund Management reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Omega Fund Management sold 5,226 Kyntra Bio shares in Q4 2021, an estimated $1.15M.
  • Omega Fund Management first reported a position in Kyntra Bio in Q4 2014 and held it in 28 quarters.
  • Omega Fund Management's Kyntra Bio position peaked at $30.5M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Omega Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.